Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Acitretin effectively treats severe hypertrophic lichen planus.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

2.5 mg/ml of triamcinolone acetonide is more effective for treating alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Spanlastics improve drug delivery by enhancing bioavailability and targeting, reducing side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.